“Raloxifene in Reducing the Risk of Postmenopausal Fracture amongst Osteoporotic Subjects”, Int. Arch. Biomed. Clin. Res., vol. 4, no. 3, pp. 4–6, Mar. 2024, doi: 10.21276/s6xhmj82.